Antimicrobial Agents Practice Questions

Q: Which of the following drugs can be used for the treatment of chloroquine-resistant malaria in children?

Clindamycin. **Explanation:** The treatment of chloroquine-resistant *Plasmodium falciparum* requires combination therapy. According to the National Vector Borne Disease Control Programme (NVBDCP) and WHO guidelines, when using Quinine for resistant malaria, it must be paired with a second antibiotic to ensure complete parasite clearance. **Why Clindamycin is Correct:** In children (especially those under 8 years of age) and pregnant women, **Clindamycin** is the drug of choice to be used in combination with Quinine. It acts by inhibiting protein synthesis via the 50S ribosomal subunit and is safe for use in pediatric populations where other options are contraindicated. **Analysis of Incorrect Options:** * **Chloroquine:** By definition, it is ineffective against chloroquine-resistant strains due to the *pfcrt* gene mutation which increases drug efflux from the parasite's food vacuole. * **Doxycycline & Tetracycline:** While these are highly effective against resistant malaria, they are **contraindicated in children under 8 years of age**. These drugs cause permanent dental discoloration (yellowish-brown staining) and can inhibit bone growth by chelating calcium in developing teeth and bones. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** For uncomplicated chloroquine-resistant malaria in India, the standard treatment is **ACT (Artemisinin-based Combination Therapy)**. * **Quinine + Clindamycin:** This is the specific regimen for resistant malaria in **pregnancy (1st trimester)** and **young children**. * **Mechanism of Resistance:** Chloroquine resistance is primarily due to mutations in the *Plasmodium falciparum* chloroquine resistance transporter (**pfcrt**) gene. * **Side Effect Note:** Always remember that Clindamycin is classically associated with *Pseudomembranous colitis* caused by *C. difficile*.

Q: Streptomycin is useful in the treatment of which of the following conditions?

Granuloma venereum. **Explanation:** Streptomycin, an aminoglycoside, is considered a second-line or alternative treatment for **Granuloma venereum** (also known as Donovanosis), caused by *Klebsiella granulomatis*. While macrolides (Azithromycin) are currently the first-line treatment, streptomycin remains a classic pharmacological association for this condition in competitive exams. **Analysis of Options:** * **Granuloma venereum (Correct):** Characterized by painless, beefy-red ulcerative lesions. Diagnosis is confirmed by identifying **Donovan bodies** (safety-pin appearance) in tissue smears. Streptomycin (1g IM twice daily) is an effective alternative therapy. * **Lymphogranuloma venereum (LGV):** Caused by *Chlamydia trachomatis* (serotypes L1-L3). The treatment of choice is **Doxycycline** or Erythromycin. Aminoglycosides like streptomycin are ineffective against intracellular *Chlamydia*. * **Syphilis:** Caused by *Treponema pallidum*. The drug of choice is **Benzathine Penicillin G**. Streptomycin has no role in treating spirochetal infections. * **Chancroid:** Caused by *Haemophilus ducreyi* (painful ulcers). The preferred treatments are **Azithromycin**, Ceftriaxone, or Ciprofloxacin. **High-Yield Clinical Pearls for NEET-PG:** * **Streptomycin Uses:** Remember the mnemonic **"T-P-G-H"**: **T**uberculosis (1st line), **P**lague (*Yersinia pestis* - Drug of Choice), **G**ranuloma venereum, and **H**uman Tularemia. * **Adverse Effects:** It is the most vestibulotoxic aminoglycoside (causing vertigo and nystagmus) and is contraindicated in pregnancy due to the risk of fetal ototoxicity. * **Mechanism:** It inhibits bacterial protein synthesis by binding to the **30S ribosomal subunit**, causing misreading of mRNA.

Q: Which one of the following statements about doxycycline is false?

It is more active than tetracycline against H. pylori. **Explanation:** The correct answer is **C**. While doxycycline is a versatile tetracycline, **tetracycline (HCl)** is specifically preferred over doxycycline in the standard quadruple therapy for *H. pylori* eradication. Clinical studies show that tetracycline achieves better mucosal concentrations and efficacy against *H. pylori* compared to doxycycline. **Analysis of Options:** * **A. It is bacteriostatic:** Like all tetracyclines, doxycycline inhibits protein synthesis by binding to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA. This action is reversible and inhibits growth rather than killing the bacteria. * **B. It is excreted mainly in the feces:** Doxycycline is unique among tetracyclines because it is primarily excreted into the gut via bile and eliminated in feces. This makes it the **tetracycline of choice in patients with renal failure**, as it does not accumulate in the blood. * **D. It is used in Lyme's disease:** Doxycycline is the **first-line drug of choice** for early-stage Lyme disease (*Borrelia burgdorferi*), as well as for Rickettsial infections and Chlamydia. **High-Yield Clinical Pearls for NEET-PG:** * **Phototoxicity:** Doxycycline is the most common tetracycline to cause skin photosensitivity. * **Contraindications:** Avoid in pregnancy and children <8 years due to permanent tooth discoloration and bone growth retardation. * **Absorption:** Unlike older tetracyclines, doxycycline absorption is **not** significantly affected by food or milk. * **Prophylaxis:** It is used for the prophylaxis of Malaria (in mefloquine-resistant areas) and Leptospirosis.

Q: Which of the following represents an orally available fixed Beta-Lactamase Inhibitor and Antibiotic Combination?

Amoxicillin-Clavulanic acid. ### Explanation The correct answer is **Amoxicillin-Clavulanic acid**. **1. Why Amoxicillin-Clavulanic acid is correct:** The primary factor determining the route of administration for beta-lactam combinations is the **acid stability** and **bioavailability** of both components. Amoxicillin is acid-stable and highly absorbed from the gastrointestinal tract. Clavulanic acid also possesses excellent oral bioavailability. Together, they form a fixed-dose combination (e.g., Augmentin) that is effective orally for community-acquired infections like sinusitis, otitis media, and animal bites. **2. Why the other options are incorrect:** * **Ampicillin-Sulbactam:** While ampicillin can be given orally, its absorption is inconsistent and decreased by food. Sulbactam has very poor oral bioavailability. Therefore, this combination is administered **parenterally** (IV/IM). (Note: *Sultamicillin* is an oral prodrug of this combination, but the standard combination listed is parenteral). * **Piperacillin-Tazobactam:** Piperacillin is a broad-spectrum antipseudonal penicillin that is degraded by gastric acid. It must be administered **intravenously**. It is a mainstay for hospital-acquired infections. * **Ticarcillin-Clavulanic Acid:** Ticarcillin is not acid-stable and is only available for **parenteral** use. **3. High-Yield NEET-PG Pearls:** * **Suicide Inhibitors:** Clavulanic acid, Sulbactam, and Tazobactam are "suicide inhibitors" because they permanently bind to and inactivate beta-lactamases. * **Newer Agents:** Avibactam and Relebactam are non-beta-lactam beta-lactamase inhibitors used with carbapenems or cephalosporins for MDR organisms. * **Sultamicillin:** This is a double ester of Ampicillin and Sulbactam, designed specifically to provide an **oral** formulation of that combination. * **Side Effect:** Amoxicillin-Clavulanate is a common cause of drug-induced cholestatic jaundice.

Q: Which monoclonal antibody neutralizes anthrax toxin?

Raxibacumab. **Explanation:** **Raxibacumab** is a recombinant human IgG1 monoclonal antibody specifically designed to treat inhalational anthrax caused by *Bacillus anthracis*. Its mechanism of action involves binding to the **Protective Antigen (PA)** component of the anthrax toxin. By neutralizing PA, it prevents the toxin from binding to host cell receptors, thereby inhibiting the entry of Lethal Factor (LF) and Edema Factor (EF) into the cells. This prevents the systemic toxemia that often leads to death even after the bacteria have been cleared by antibiotics. (Note: **Obiltoxaximab** is another mAb with a similar mechanism). **Analysis of Incorrect Options:** * **Cetuximab:** A chimeric monoclonal antibody that targets the **Epidermal Growth Factor Receptor (EGFR)**. It is primarily used in the treatment of metastatic colorectal cancer and head and neck squamous cell carcinoma. * **Panitumumab:** A fully human monoclonal antibody that also targets **EGFR**. It is used for the treatment of EGFR-expressing metastatic colorectal cancer. * **Alemtuzumab:** A monoclonal antibody directed against **CD52**, a protein found on the surface of mature lymphocytes. It is used in the treatment of B-cell chronic lymphocytic leukemia (CLL) and Multiple Sclerosis (MS). **High-Yield Clinical Pearls for NEET-PG:** * **Anthrax Toxin Components:** It is a tripartite toxin consisting of Protective Antigen (PA), Lethal Factor (LF), and Edema Factor (EF). * **Drug of Choice:** While Raxibacumab manages the toxin, the antibiotic drug of choice for post-exposure prophylaxis and treatment of Anthrax is **Ciprofloxacin** (or Doxycycline). * **Bezlotoxumab:** Do not confuse Raxibacumab with Bezlotoxumab, which is a monoclonal antibody used to prevent the recurrence of *Clostridioides difficile* infection by neutralizing Toxin B.

Q: Tecovirimat is a recently approved anti-viral drug. Against which virus is it used?

Smallpox. **Explanation:** **Tecovirimat** is a novel, first-in-class antiviral medication specifically developed and approved for the treatment of **Smallpox** (caused by the *Variola virus*). It was approved by the FDA under the "Animal Rule" to bolster biodefense preparedness. **Mechanism of Action:** Tecovirimat works by inhibiting the **VP37 envelope wrapping protein**, which is highly conserved across orthopoxviruses. By blocking this protein, the drug prevents the formation of egress-competent enveloped virions, thereby stopping the virus from spreading from cell to cell within the host. **Analysis of Incorrect Options:** * **B. Chickenpox:** Caused by the *Varicella-Zoster Virus* (a herpesvirus). The standard treatment involves DNA polymerase inhibitors like **Acyclovir** or Valacyclovir. Tecovirimat is ineffective against herpesviruses. * **C. Dengue:** A flavivirus for which there is currently no specific antiviral therapy. Management is primarily supportive (fluid resuscitation). * **D. Influenza:** Treated with neuraminidase inhibitors (e.g., **Oseltamivir**), endonuclease inhibitors (e.g., **Baloxavir marboxil**), or M2 ion channel blockers (e.g., Amantadine). **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** While approved for Smallpox, it also shows efficacy against other orthopoxviruses, including **Mpox (Monkeypox)** and Cowpox. * **Route:** Available in both oral and intravenous formulations. * **Resistance:** Resistance can develop via a single amino acid substitution in the VP37 protein; hence, it is often reserved for severe cases or biosecurity threats. * **Key Target:** Remember **VP37**—this is a frequent target for "mechanism of action" questions in recent exams.

Q: All of the following drugs inhibit cell wall synthesis except?

Tetracycline. **Explanation:** The cell wall is a vital structure in bacteria, and drugs targeting its synthesis are generally bactericidal. To answer this question, one must distinguish between cell wall synthesis inhibitors and protein synthesis inhibitors. **Why Tetracycline is the correct answer:** **Tetracycline** is a bacteriostatic antibiotic that inhibits **protein synthesis**, not cell wall synthesis. It acts by reversibly binding to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. **Why the other options are incorrect:** * **Penicillin:** A Beta-lactam antibiotic that inhibits the final step of cell wall synthesis (transpeptidation) by binding to Penicillin-Binding Proteins (PBPs). * **Fosfomycin:** Inhibits the very first step of peptidoglycan synthesis by inhibiting the enzyme **MurA** (enolpyruvate transferase), preventing the formation of UDP-NAM. * **Vancomycin:** A glycopeptide that inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, preventing transglycosylation and transpeptidation. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cell Wall Inhibitors:** "**P**enis **C**an't **B**eat **V**irgin **F**annies" (**P**enicillins, **C**ephalosporins, **B**acitracin, **V**ancomycin, **F**osfomycin/Cycloserine). * **Tetracycline Side Effects:** Fanconi syndrome (expired tetracyclines), tooth discoloration, and phototoxicity. * **Fosfomycin** is a first-line drug for uncomplicated UTIs (safe in pregnancy). * **Vancomycin** is the drug of choice for MRSA but can cause "Red Man Syndrome" due to histamine release if infused too rapidly.

Q: What is the drug of choice for treating P. vivax malaria in a pregnant woman?

Chloroquine. ### Explanation **Correct Option: B. Chloroquine** **Mechanism and Rationale:** Chloroquine remains the **drug of choice (DOC)** for sensitive *Plasmodium vivax* and *P. falciparum* malaria during all trimesters of pregnancy. It is highly effective against the erythrocytic stages of the parasite and has a well-established safety profile in pregnancy, showing no teratogenic effects. In *P. vivax* cases, Chloroquine clears the current infection; however, **Primaquine**, which is used for radical cure (to kill hypnozoites in the liver), is **strictly contraindicated** in pregnancy due to the risk of severe hemolysis in the fetus (who may be G6PD deficient). Therefore, pregnant women are maintained on Chloroquine prophylaxis until delivery. **Analysis of Incorrect Options:** * **A. Quinine:** While safe in pregnancy, it is generally reserved for Chloroquine-resistant malaria or severe/complicated malaria. It is not the first-line choice for uncomplicated *P. vivax*. * **C. Artemether:** Part of Artemisinin-based Combination Therapy (ACT). While ACTs are now used in the 2nd and 3rd trimesters for *P. falciparum*, Chloroquine is still preferred for *P. vivax* unless resistance is documented. * **D. Paracetamol:** This is an antipyretic used for symptomatic relief of fever; it has no antimalarial activity and cannot treat the underlying infection. **High-Yield Clinical Pearls for NEET-PG:** * **Radical Cure Delay:** In *P. vivax* pregnancy cases, give Chloroquine (treatment) followed by weekly Chloroquine (prophylaxis) until delivery. Administer Primaquine only **after** delivery and after checking the G6PD status of the mother and infant. * **Severe Malaria in Pregnancy:** Intravenous **Artesunate** is the DOC for severe malaria in all trimesters (benefits outweigh risks). * **Contraindicated in Pregnancy:** Primaquine, Pyrimethamine (relative), and Tetracyclines (Doxycycline).

Q: Which of the following is a Dihydropteroate synthase (DHPS) inhibitor?

Dapsone. ### Explanation **Mechanism of Action: Folic Acid Synthesis Inhibition** Bacteria and certain protozoa must synthesize their own folic acid to produce DNA. This pathway occurs in two major steps: 1. **Step 1:** PABA (Para-aminobenzoic acid) is converted to Dihydrofolic acid by the enzyme **Dihydropteroate synthase (DHPS)**. 2. **Step 2:** Dihydrofolic acid is converted to Tetrahydrofolic acid by the enzyme **Dihydrofolate reductase (DHFR)**. **Dapsone** (a sulfone) is a structural analog of PABA. It competitively inhibits **Dihydropteroate synthase (DHPS)**, thereby halting the synthesis of folic acid. This is the same mechanism used by Sulfonamides (e.g., Sulfadiazine). --- ### Analysis of Options * **D. Dapsone (Correct):** As a sulfone, it specifically targets DHPS. It is a cornerstone drug in the MDT (Multi-Drug Therapy) for Leprosy. * **A. Pyrimethamine (Incorrect):** This is a **DHFR inhibitor** primarily used in the treatment of Toxoplasmosis and Malaria. * **B. Trimethoprim (Incorrect):** This is a potent bacterial **DHFR inhibitor**. It is commonly combined with Sulfamethoxazole (a DHPS inhibitor) to create a sequential blockade (Cotrimoxazole). * **C. Methotrexate (Incorrect):** This is a human **DHFR inhibitor** used as a cytotoxic chemotherapy agent and an immunosuppressant (e.g., in Rheumatoid Arthritis). --- ### NEET-PG High-Yield Pearls * **Sequential Blockade:** Combining a DHPS inhibitor (Sulfonamide) with a DHFR inhibitor (Trimethoprim) results in synergistic bactericidal activity. * **Dapsone Side Effects:** Most common is **Hemolysis** (especially in G6PD deficient patients) and **Methemoglobinemia**. * **Lepra Reaction:** Dapsone is continued during Type 1 reactions but may be associated with the "Dapsone Syndrome" (sulfone syndrome), characterized by fever, dermatitis, and hepatitis.

Question 1

Which of the following drugs can be used for the treatment of chloroquine-resistant malaria in children?

Accepted Answer

Clindamycin

Answer

Chloroquine

Answer

Doxycycline

Answer

Tetracycline

Question 2

Pyrantel pamoate is effective in which of the following parasitic infections?

Accepted Answer

Enterobius and ascariasis

Answer

Amoebiasis and trichuriasis

Answer

Amoebiasis and strongyloides

Answer

Taenia solium and ascariasis

Question 3

Streptomycin is useful in the treatment of which of the following conditions?

Accepted Answer

Granuloma venereum

Answer

Lymphogranuloma venereum (LGV)

Answer

Syphilis

Answer

Chancroid

Question 4

Which one of the following statements about doxycycline is false?

Accepted Answer

It is more active than tetracycline against H. pylori

Answer

It is bacteriostatic

Answer

It is excreted mainly in the feces

Answer

It is used in Lyme's disease

Question 5

Which of the following represents an orally available fixed Beta-Lactamase Inhibitor and Antibiotic Combination?

Accepted Answer

Amoxicillin-Clavulanic acid

Answer

Ampicillin-Sulbactam

Answer

Piperacillin-Tazobactam

Answer

Ticarcillin-Clavulanic Acid

Question 6

Which monoclonal antibody neutralizes anthrax toxin?

Accepted Answer

Raxibacumab

Answer

Cetuximab

Answer

Panitumumab

Answer

Alemtuzumab

Question 7

Tecovirimat is a recently approved anti-viral drug. Against which virus is it used?

Accepted Answer

Smallpox

Answer

Chickenpox

Answer

Dengue

Answer

Influenza

Question 8

All of the following drugs inhibit cell wall synthesis except?

Accepted Answer

Tetracycline

Answer

Penicillin

Answer

Fosfomycin

Answer

Vancomycin

Question 9

What is the drug of choice for treating P. vivax malaria in a pregnant woman?

Accepted Answer

Chloroquine

Answer

Quinine

Answer

Artemether

Answer

Paracetamol

Question 10

Which of the following is a Dihydropteroate synthase (DHPS) inhibitor?

Accepted Answer

Dapsone

Answer

Pyrimethamine

Answer

Trimethoprim

Answer

Methotrexate

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?